目的 探讨肾小球系膜区微量IgM 沉积在儿童微小病变型原发性肾病综合征(PNS)中的意义。方法 以临床诊断为PNS、病理诊断为微小病变(MCD)及肾组织微量IgM 沉积的106 例患儿为研究组,无免疫复合物沉积的MCD 型PNS 患儿81 例为对照组,回顾性分析两组患儿的临床特点、微量IgM 沉积对糖皮质激素及免疫抑制剂疗效的影响。患儿均口服足量泼尼松治疗,对糖皮质激素耐药者或频复发者联用免疫抑制剂治疗。结果 研究组糖皮质激素耐药率高于对照组(27.2% vs 12.3%,P<0.05);研究组频复发率亦高于对照组(48.1%vs 10.4%,P<0.05)。研究组和对照组中糖皮质激素耐药的病例联用吗替麦考酚酯(MMF)治疗的完全缓解率分别为68%(13/19)、62%(8/13),两组比较差异无统计学意义(P>0.05)。研究组和对照组频复发病例联用MMF 治疗后复发频率均显著减少(P<0.05)。结论 MCD 型PNS 患儿肾脏的微量IgM 沉积可能是糖皮质激素耐药及频复发的重要因素;糖皮质激素耐药及频复发患儿联用MMF 治疗可能是较好的治疗方案。
Abstract
Objective To study the significance of trace immunoglobulin M (IgM) deposits in glomerular mesangium in children with minimal change primary nephrotic syndrome (PNS). Methods One hundred and six children who were clinically diagnosed with PNS and pathologically diagnosed with minimal change disease (MCD) and trace deposition of IgM in renal tissues were enrolled as subjects. Eighty-one PNS children with MCD but no deposition of immune complexes were used as the control group. The clinical characteristics and efficacies of glucocorticoids and immunosuppressants were retrospectively analyzed in the two groups. All patients were given full-dose prednisone by oral administration, and patients with glucocorticoid resistance or frequent relapses were additionally given immunosuppressants. Results The incidence of glucocorticoid resistance in the IgM deposit group was significantly higher than that in the control group (27.2% vs 12.3%; P<0.05). The incidence of frequent relapses in the IgM deposit group was also significantly higher than that in the control group (48.1% vs 10.4%; P<0.05). The complete remission rate for glucocorticoid-resistant patients treated with prednisone combined with mycophenolate mofetil (MMF) was 68% and 62% respectively in the IgM deposit and control groups (P>0.05). The relapse frequency in patients with frequent relapses was significantly reduced in both groups after treatment with prednisone and MMF in combination (P<0.05). Conclusions Trace deposition of IgM in renal tissues may be an important factor for glucocorticoid resistance and frequent relapses in PNS children with MCD. Prednisone combined with MMF may be a better choice in the treatment of patients with glucocorticoid resistance or frequent relapses.
关键词
肾病综合征 /
微小病变 /
免疫球蛋白M /
糖皮质激素 /
吗替麦考酚酯 /
儿童
Key words
Nephrotic syndrome /
Minimal change disease /
Immunoglobulin M /
Glucocorticoid /
Mycophenolate mofetil /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 党西强, 易著文, 何小解, 等. 1316 例小儿肾脏病临床与病 理分布特点[J]. 中国当代儿科杂志, 2007, 9(2): 117-121.
[2] 曾华松, 高岩, 徐家喻, 等. 小儿肾病综合征肾脏病理与脂 质紊乱的关系[J]. 中国当代儿科杂志, 2001, 3(2): 151-153.
[3] 马祖祥, 易著文, 赵维玲, 等. 原发性肾病综合征患儿肾组 织中p18 的表达及意义( 英文)[J]. 中国当代儿科杂志, 2004, 6(5): 373-377.
[4] Report of the International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation[J]. Pediatrics, 1984, 73(4): 497-501.
[5] 朱碧溱, 丁洁. IgM 肾病[J]. 临床儿科杂志, 2012, 30(4): 389-392.
[6] 郑莉萍, 王华, 张建江, 等. 34 例儿童IgM 肾病临床与病理 分析[J]. 中国当代儿科杂志, 2010, 12(5): 338-340.
[7] 李先法, 朱彩凤, 朱斌, 等. 原发性局灶节段性肾小球硬化 伴IgM 沉积患者的临床特征及预后分析[J]. 中华肾脏病杂志, 2013, 29(10): 737-742.
[8] 中华医学会儿科学分会肾脏病学组. 小儿肾小球疾病的临床 分类、诊断及治疗[J]. 中华儿科杂志, 2001, 39(12): 746-749.
[9] 中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治 循证指南( 一): 激素敏感、复发/依赖肾病综合征诊治循证 指南( 试行)[J]. 中华儿科杂志, 2009, 47(3): 167-170.
[10] Saha TC, Singh H. Minimal change disease: a review[J]. South Med J, 2006, 99(11): 1264-1270.
[11] Welch TR, McAdams J. Immunoglobulin M and C1q mesangial labeling in IgA nephropathy[J]. Am J Kidney Dis, 1998, 32(4): 589-592.
[12] Kanemoto K, Ito H, Anzai M, et al. Clinical significance of IgM and C1q deposition in the mesangium in pediatric idiopathic nephrotic syndrome[J]. J Nephrol, 2013, 26(2): 306-314.
[13] Swartz SJ, Eldin KW, Hicks MJ, et al. Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome[J]. Pediatr Nephrol, 2009, 24(6): 1187-1192.
[14] Maruyama M, Toyoda M, Umezono T, et al. Clinical significance of IgM deposition in the mesangium and mesangial hypercellularity in adult minimal change nephrotic syndrome[J]. Nihon Jinzo Gakkai Shi, 2006, 48(1): 14-21.
[15] 任献国, 刘光陵, 夏正坤, 等. 儿童微小病变性肾病综合征 临床分析[J]. 中国全科医学, 2011, 14(26): 3025-3027.
[16] Banaszak B, Banaszak P. The increasing incidence of initial steroid resistance in childhood nephrotic syndrome[J]. Pediatr Nephrol, 2012, 27(6): 927-932.
[17] Zeis PM, Kavazarakis E, Nakopoulou L, et al. Glomerulopathy with mesangial IgM deposits: long-term follow up of 64 children[J]. Pediatr Int, 2001, 43(3): 287-292.
[18] Arias LF, Prada MC, Vélez-Echeverri C, et al. IgM nephropathy in children: clinicopathologic analysis[J]. Nefrologia, 2013, 33(4): 532-538.
[19] Li Z, Duan C, He J, et al. Cyclopentolate mofetil therapy for children with steroid-resistant nephrotic syndrome[J]. Pediatr Nephrol, 2010, 25(5): 883-888.
基金
湖南省高层次卫生人才“225”工程资助[湘卫人发(2013)13 号]。
PDF(1156 KB)
